drugset / Trial / NCT04347135
Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI
NaSingle-groupOpen-labelDiagnostic
Summary
Researchers are trying to improve the detection of endometriosis using F-18 FES PET/MRI imaging.
Timeline
- Start
- 2022-10-07
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | F-18 16 Alpha-Fluoroestradiol | Diagnostic / imaging agent | — | — |